Alternative Surgical Strategies and Favorable Outcomes in Patients with Medullary Thyroid Carcinoma in Japan: Experience of a Single Institution
- 13 November 2008
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 33 (1) , 58-66
Abstract
Background: Medullary thyroid carcinoma (MTC) accounts only for 1.4% of all thyroid malignancies in Japan. Since 1996, we have performed hemithyroidectomy, instead of total thyroidectomy, for sporadic nonhereditary MTC when the primary lesion is located in only one lobe. Regarding lymph node dissection, modified radical neck dissection (MND) at least ipsilateral to the tumor has been routinely performed, even if there is no clinically apparent metastasis. We investigated the clinical outcomes of MTC patients in our department.Methods: A series of 118 patients with MTC who underwent initial surgery between 1975 and 2005 were enrolled in this study. The RET gene mutations were analyzed for all patients and 46 had germline RET gene mutations. Of those 46 patients, 26 were diagnosed as MEN 2A and 2 were diagnosed as MEN 2B. Postoperative follow‐up periods averaged 141 months.Results: Of 115 patients who did not have distant metastasis at surgery and who underwent locally curative surgery, 78 (67.8%) were biochemically cured. All patients without pathological lymph node metastasis were biochemically cured, and 44.8% of patients with node metastasis were also biochemically cured. The 10‐year and 20‐year disease‐free survival rates were 89.0% and 82.5%, respectively. None of the patients who did not show lymph node metastasis and only 2 (2.6%) of 78 patients who were biochemically cured showed clinically apparent carcinoma recurrence. The 10‐year and 20‐year cause‐specific survival rates were 96.6% and 91.7%, respectively. Lymph node metastasis, tumor size >4 cm, extrathyroid and extranodal tumor extensions significantly affected cause‐specific survival of patients.Conclusions: Clinical outcomes of MTC patients in our series were better than those in Western countries, a result that might have resulted in part because of our routine MND regardless of whether clinically apparent node metastasis was detected.Keywords
This publication has 34 references indexed in Scilit:
- Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year resultsEuropean Journal of Endocrinology, 2007
- Determinants of life expectancy in medullary thyroid cancer: age does not matterClinical Endocrinology, 2006
- Prognostic Variables and Calcitonin in Medullary Thyroid CancerThe Laryngoscope, 2005
- Changing Impact of Gastroesophageal Reflux in Medical and Otolaryngology PracticeThe Laryngoscope, 2005
- Familial medullary thyroid cancer: clinical aspects and prognosisEuropean Journal of Surgical Oncology, 2005
- Postoperative calcitonin study in medullary thyroid carcinoma.Endocrine-Related Cancer, 2004
- Multiple endocrine neoplasia type 2B — genetic basis and clinical expressionSurgical Oncology, 2000
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Medullary Thyroid Carcinoma: Clinicopathologic Features and Long-Term Follow-Up of 65 Patients Treated During 1946 Through 1970Mayo Clinic Proceedings, 1992